BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22051973)

  • 1. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.
    Shin SK; Pack SP; Oh JG; Kang NK; Chang MH; Chung YH; Kim SJ; Lee JW; Heo TH
    Int Immunopharmacol; 2011 Dec; 11(12):2237-41. PubMed ID: 22051973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
    Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
    J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure red cell aplasia and anti-erythropoietin antibodies in patients on hemodialysis: a report of two cases and a literature review.
    Lacreta G; Bucharles SGE; Sevignani G; Riella MC; Nascimento MMD
    J Bras Nefrol; 2019; 41(1):145-151. PubMed ID: 30160771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
    Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
    Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin.
    Shimizu H; Saitoh T; Ota F; Jimbo T; Tsukada Y; Murakami H; Nojima Y
    Acta Haematol; 2011; 126(2):114-8. PubMed ID: 21654161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure red cell aplasia secondary to epoetin alpha responding to Darbepoetin alpha in a patient on peritoneal dialysis.
    Asari A; Gokal R
    J Am Soc Nephrol; 2004 Aug; 15(8):2204-7. PubMed ID: 15284306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.
    Lee H; Yang J; Kim H; Kwon JW; Oh KH; Joo KW; Kim YS; Ahn C; Han JS; Kim S
    J Korean Med Sci; 2010 Nov; 25(11):1676-9. PubMed ID: 21060762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
    Lim SK; Bee PC; Keng TC; Chong YB
    Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepoetin antibody-related pure red cell aplasia: successful remission with cessation of recombinant erythropoietin alone.
    Katagiri D; Shibata M; Katsuki T; Masumoto S; Katsuma A; Minami E; Hoshino T; Inoue T; Tada M; Hinoshita F
    Clin Exp Nephrol; 2010 Oct; 14(5):501-5. PubMed ID: 20652821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.
    Casadevall N; Nataf J; Viron B; Kolta A; Kiladjian JJ; Martin-Dupont P; Michaud P; Papo T; Ugo V; Teyssandier I; Varet B; Mayeux P
    N Engl J Med; 2002 Feb; 346(7):469-75. PubMed ID: 11844847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of recombinant human erythropoietin in Korea: a two-year cross-sectional study.
    Shin SK; Moon SJ; Ha SK; Jo YI; Lee TW; Lee YS; Kim YW; Kim DJ; Kim JK; Yoo TH; Lee KB; Choi SO; Kang EW; Lee KW; Kim SJ; Kim SK; Heo TH
    Biologicals; 2012 Jul; 40(4):254-61. PubMed ID: 22391230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
    Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
    Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
    Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.
    Wu G; Wadgymar A; Wong G; Ting R; Nathoo B; Mendelssohn D; Pandeya S; Sapir D; Tam P
    Am J Kidney Dis; 2004 Aug; 44(2):264-9. PubMed ID: 15264184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple screening test for the detection of erythropoietin antibodies.
    Meran S; Wonnacott A; Davies M; Ellis R; Phillips A
    Clin Nephrol; 2014 Sep; 82(3):215-20. PubMed ID: 23391321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
    Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A
    J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
    Viron B; Dupuy CA; Kolta A; Casadevall N
    Nephrol Dial Transplant; 2008 Jul; 23(7):2416-8. PubMed ID: 18388118
    [No Abstract]   [Full Text] [Related]  

  • 20. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures.
    Thorpe R; Swanson SJ
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv16-22. PubMed ID: 15827053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.